Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Theodore Lawrence

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Anatomy

Cultured Tumor Cells

Disorders

Concepts & Ideas

Procedures

Physiology

Living Beings

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Contessa Joseph N; Griffith Kent A; Wolff Elizabeth; Ensminger William; Zalupski Mark; Lawrence Theodore S; Ben-Josef Edgar
Radiotherapy for pancreatic neuroendocrine tumors.
Zielske Steven P; Livant Donna L; Lawrence Theodore S
Radiation increases invasion of gene-modified mesenchymal stem cells into tumors.
Dai Yao; DeSano Jeffrey T; Meng Yang; Ji Qing; Ljungman Mats; Lawrence Theodore S; Xu Liang
Celastrol potentiates radiotherapy by impairment of DNA damage processing in human prostate cancer.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Theodore Lawrence (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Contessa Joseph N; Griffith Kent A; Wolff Elizabeth; Ensminger William; Zalupski Mark; Lawrence Theodore S; Ben-Josef Edgar
Radiotherapy for pancreatic neuroendocrine tumors.
International journal of radiation oncology, biology, physics 2009;75(4):1196-200.
2009: Zielske Steven P; Livant Donna L; Lawrence Theodore S
Radiation increases invasion of gene-modified mesenchymal stem cells into tumors.
International journal of radiation oncology, biology, physics 2009;75(3):843-53.
2009: Dai Yao; DeSano Jeffrey T; Meng Yang; Ji Qing; Ljungman Mats; Lawrence Theodore S; Xu Liang
Celastrol potentiates radiotherapy by impairment of DNA damage processing in human prostate cancer.
International journal of radiation oncology, biology, physics 2009;74(4):1217-25.
2009: Tsien Christina I; Cao Yue; Lawrence Theodore S
Functional and metabolic magnetic resonance imaging and positron emission tomography for tumor volume definition in high-grade gliomas.
Seminars in radiation oncology 2009;19(3):155-62.
2009: Ahsan Aarif; Hiniker Susan M; Davis Mary A; Lawrence Theodore S; Nyati Mukesh K
Role of cell cycle in epidermal growth factor receptor inhibitor-mediated radiosensitization.
Cancer research 2009;69(12):5108-14.
2009: Galbán Craig J; Chenevert Thomas L; Meyer Charles R; Tsien Christina; Lawrence Theodore S; Hamstra Daniel A; Junck Larry; Sundgren Pia C; Johnson Timothy D; Ross David J; Rehemtulla Alnawaz; Ross Brian D
The parametric response map is an imaging biomarker for early cancer treatment outcome.
Nature medicine 2009;15(5):572-6.
2009: Cao Yue; Tsien Christina I; Sundgren Pia C; Nagesh Vijaya; Normolle Daniel; Buchtel Henry; Junck Larry; Lawrence Theodore S
Dynamic contrast-enhanced magnetic resonance imaging as a biomarker for prediction of radiation-induced neurocognitive dysfunction.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(5):1747-54.
2009: Sundgren P C; Nagesh V; Elias A; Tsien C; Junck L; Gomez Hassan D M; Lawrence T S; Chenevert T L; Rogers L; McKeever P; Cao Y
Metabolic alterations: a biomarker for radiation-induced normal brain injury-an MR spectroscopy study.
Journal of magnetic resonance imaging : JMRI 2009;29(2):291-7.
2009: Lee Irwin H; Piert Morand; Gomez-Hassan Diana; Junck Larry; Rogers Lisa; Hayman James; Ten Haken Randall K; Lawrence Theodore S; Cao Yue; Tsien Christina
Association of 11C-methionine PET uptake with site of failure after concurrent temozolomide and radiation for primary glioblastoma multiforme.
International journal of radiation oncology, biology, physics 2009;73(2):479-85.
2009: Parsels Leslie A; Morgan Meredith A; Tanska Daria M; Parsels Joshua D; Palmer Brian D; Booth R John; Denny William A; Canman Christine E; Kraker Alan J; Lawrence Theodore S; Maybaum Jonathan
Gemcitabine sensitization by checkpoint kinase 1 inhibition correlates with inhibition of a Rad51 DNA damage response in pancreatic cancer cells.
Molecular cancer therapeutics 2009;8(1):45-54.
2009: Ji Qing; Hao Xinbao; Zhang Min; Tang Wenhua; Yang Meng; Li Ling; Xiang Debing; Desano Jeffrey T; Bommer Guido T; Fan Daiming; Fearon Eric R; Lawrence Theodore S; Xu Liang
MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells.
PloS one 2009;4(8):e6816.
2009: Ao Xiaoping; Zhao Lujun; Davis Mary A; Lubman David M; Lawrence Theodore S; Kong Feng-Ming
Radiation produces differential changes in cytokine profiles in radiation lung fibrosis sensitive and resistant mice.
Journal of hematology & oncology 2009;2():6.
2008: Spalding Aaron C; Zeitlin Benjamin D; Wilder-Romans Kari; Davis Mary E; Nor Jacques E; Lawrence Theodore S; Ben-Josef Edgar
Enzastaurin, an inhibitor of PKCbeta, Enhances Antiangiogenic Effects and Cytotoxicity of Radiation against Endothelial Cells.
Translational oncology 2008;1(4):195-201.
2008: Morgan Meredith A; Parsels Leslie A; Maybaum Jonathan; Lawrence Theodore S
Improving gemcitabine-mediated radiosensitization using molecularly targeted therapy: a review.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(21):6744-50.
2008: Dorfman Gary S; Lawrence Theodore S; Matrisian Lynn M;
The Translational Research Working Group developmental pathway for interventive devices.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(18):5700-6.
2008: Morgan Meredith A; Parsels Leslie A; Kollar Laura E; Normolle Daniel P; Maybaum Jonathan; Lawrence Theodore S
The combination of epidermal growth factor receptor inhibitors with gemcitabine and radiation in pancreatic cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(16):5142-9.
2008: Abela R A; Qian J; Xu L; Lawrence T S; Zhang M
Radiation improves gene delivery by a novel transferrin-lipoplex nanoparticle selectively in cancer cells.
Cancer gene therapy 2008;15(8):496-507.
2008: Hamstra Daniel A; Galbán Craig J; Meyer Charles R; Johnson Timothy D; Sundgren Pia C; Tsien Christina; Lawrence Theodore S; Junck Larry; Ross David J; Rehemtulla Alnawaz; Ross Brian D; Chenevert Thomas L
Functional diffusion map as an early imaging biomarker for high-grade glioma: correlation with conventional radiologic response and overall survival.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(20):3387-94.
2008: Contessa Joseph N; Bhojani Mahaveer S; Freeze Hudson H; Rehemtulla Alnawaz; Lawrence Theodore S
Inhibition of N-linked glycosylation disrupts receptor tyrosine kinase signaling in tumor cells.
Cancer research 2008;68(10):3803-9.
2008: Ben-Josef Edgar; Lawrence Theodore S
Chemoradiotherapy for unresectable pancreatic cancer.
International journal of clinical oncology / Japan Society of Clinical Oncology 2008;13(2):121-6.
2008: Kong Feng-Ming; Ao Xiaoping; Wang Li; Lawrence Theodore S
The use of blood biomarkers to predict radiation lung toxicity: a potential strategy to individualize thoracic radiation therapy.
Cancer control : journal of the Moffitt Cancer Center 2008;15(2):140-50.
2008: Ao Xiaoping; Lubman David M; Davis Mary A; Xing Xianying; Kong Feng-Ming; Lawrence Theodore S; Zhang Ming
Comparative proteomic analysis of radiation-induced changes in mouse lung: fibrosis-sensitive and -resistant strains.
Radiation research 2008;169(4):417-25.
2008: Morgan Meredith A; Meirovitz Amichay; Davis Mary A; Kollar Laura E; Hassan Maria C; Lawrence Theodore S
Radiotherapy combined with gemcitabine and oxaliplatin in pancreatic cancer cells.
Translational oncology 2008;1(1):36-43.
2008: Morgan Meredith; El Shaikh Mohamed A; Abu-Isa Eyad; Davis Mary A; Lawrence Theodore S
Radiosensitization by gemcitabine fixed-dose-rate infusion versus bolus injection in a pancreatic cancer model.
Translational oncology 2008;1(1):44-9.
2008: Thomas Melanie B; Lawrence Theodore S
From the guest editors. Hepatocellular carcinoma.
Cancer journal (Sudbury, Mass.) 2008;14(2):94.
2008: Zhang Ming; Qian Jun; Xing Xianying; Kong Feng-Ming; Zhao Lujun; Chen Ming; Lawrence Theodore S
Inhibition of the tumor necrosis factor-alpha pathway is radioprotective for the lung.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(6):1868-76.
2008: Nagesh Vijaya; Tsien Christina I; Chenevert Thomas L; Ross Brian D; Lawrence Theodore S; Junick Larry; Cao Yue
Radiation-induced changes in normal-appearing white matter in patients with cerebral tumors: a diffusion tensor imaging study.
International journal of radiation oncology, biology, physics 2008;70(4):1002-10.
2008: Zhao Lujun; Sheldon Kerby; Chen Ming; Yin Moli S; Hayman James A; Kalemkerian Gregory P; Arenberg Doug; Lyons Susan E; Curtis Jeffrey L; Davis Mary; Cease Kemp B; Brenner Dean; Anscher Mitchell S; Lawrence Theodore S; Kong Feng Ming
The predictive role of plasma TGF-beta1 during radiation therapy for radiation-induced lung toxicity deserves further study in patients with non-small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2008;59(2):232-9.
2008: Lawrence Theodore S
Radiotherapy for intrahepatic cancers: the promise of emerging sophisticated techniques.
The journal of supportive oncology 2008;6(1):14-5.
2008: Cao Yue; Pan Charlie; Balter James M; Platt Joel F; Francis Isaac R; Knol James A; Normolle Daniel; Ben-Josef Edgar; Ten Haken Randall K; Lawrence Theodore S
Liver function after irradiation based on computed tomographic portal vein perfusion imaging.
International journal of radiation oncology, biology, physics 2008;70(1):154-60.
2007: Spalding Aaron C; Watson Richard; Davis Mary E; Kim Alex C; Lawrence Theodore S; Ben-Josef Edgar
Inhibition of protein kinase Cbeta by enzastaurin enhances radiation cytotoxicity in pancreatic cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(22 Pt 1):6827-33.
2007: Ben-Josef Edgar; Lawrence Theodore S; Zalupski Mark M
Radiotherapy for locally advanced pancreatic cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(30):4861.
2007: Desai Sameer P; Ben-Josef Edgar; Normolle Daniel P; Francis Isaac R; Greenson Joel K; Simeone Diane M; Chang Alfred E; Colletti Lisa M; Lawrence Theodore S; Zalupski Mark M
Phase I study of oxaliplatin, full-dose gemcitabine, and concurrent radiation therapy in pancreatic cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(29):4587-92.
2007: Nagesh Vijaya; Chenevert Thomas L; Tsien Christina I; Ross Brian D; Lawrence Theodore S; Junck Larry; Cao Yue
Quantitative characterization of hemodynamic properties and vasculature dysfunction of high-grade gliomas.
NMR in biomedicine 2007;20(6):566-77.
2007: Shewach Donna S; Lawrence Theodore S
Antimetabolite radiosensitizers.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(26):4043-50.
2007: Lopez Carlos A; Feng Felix Y; Herman Joseph M; Nyati Mukesh K; Lawrence Theodore S; Ljungman Mats
Phenylbutyrate sensitizes human glioblastoma cells lacking wild-type p53 function to ionizing radiation.
International journal of radiation oncology, biology, physics 2007;69(1):214-20.
2007: Kong Feng-Ming Spring; Frey Kirk A; Quint Leslie E; Ten Haken Randall K; Hayman James A; Kessler Marc; Chetty Indrin J; Normolle Daniel; Eisbruch Avraham; Lawrence Theodore S
A pilot study of [18F]fluorodeoxyglucose positron emission tomography scans during and after radiation-based therapy in patients with non small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(21):3116-23.
2007: Murphy James D; Adusumilli Saroja; Griffith Kent A; Ray Michael E; Zalupski Mark M; Lawrence Theodore S; Ben-Josef Edgar
Full-dose gemcitabine and concurrent radiotherapy for unresectable pancreatic cancer.
International journal of radiation oncology, biology, physics 2007;68(3):801-8.
2007: Feng F Y; Varambally S; Tomlins S A; Chun P Y; Lopez C A; Li X; Davis M A; Chinnaiyan A M; Lawrence T S; Nyati M K
Role of epidermal growth factor receptor degradation in gemcitabine-mediated cytotoxicity.
Oncogene 2007;26(23):3431-9.
2007: Feng Felix Y; Lopez Carlos A; Normolle Daniel P; Varambally Sooryanarayana; Li Xiaoxin; Chun Patrick Y; Davis Mary A; Lawrence Theodore S; Nyati Mukesh K
Effect of epidermal growth factor receptor inhibitor class in the treatment of head and neck cancer with concurrent radiochemotherapy in vivo.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(8):2512-8.
2007: Cao Yue; Platt Joel F; Francis Isaac R; Balter James M; Pan Charlie; Normolle Daniel; Ben-Josef Edgar; Haken Randall K Ten; Lawrence Theodore S
The prediction of radiation-induced liver dysfunction using a local dose and regional venous perfusion model.
Medical physics 2007;34(2):604-12.
2007: Spalding Aaron C; Jee Kyung-Wook; Vineberg Karen; Jablonowski Marla; Fraass Benedick A; Pan Charlie C; Lawrence Theodore S; Haken Randall K Ten; Ben-Josef Edgar
Potential for dose-escalation and reduction of risk in pancreatic cancer using IMRT optimization with lexicographic ordering and gEUD-based cost functions.
Medical physics 2007;34(2):521-9.
2006: Nyati Mukesh K; Feng Felix Y; Maheshwari Divya; Varambally Sooryanarayana; Zielske Steven P; Ahsan Aarif; Chun Patrick Y; Arora Vinay A; Davis Mary A; Jung Mira; Ljungman Mats; Canman Christine E; Chinnaiyan Arul M; Lawrence Theodore S
Ataxia telangiectasia mutated down-regulates phospho-extracellular signal-regulated kinase 1/2 via activation of MKP-1 in response to radiation.
Cancer research 2006;66(24):11554-9.
2006: Ten Haken Randall K; Lawrence Theodore S; Dawson Laura A
Prediction of radiation-induced liver disease by Lyman normal-tissue complication probability model in three-dimensional conformal radiation therapy for primary liver carcinoma: in regards to Xu et al. (Int J Radiat Oncol Biol Phys 2006;65:189-195).
International journal of radiation oncology, biology, physics 2006;66(4):1272; author reply 1272-3.
2006: Nyati Mukesh K; Morgan Meredith A; Feng Felix Y; Lawrence Theodore S
Integration of EGFR inhibitors with radiochemotherapy.
Nature reviews. Cancer 2006;6(11):876-85.
2006: Ben-David Merav A; Griffith Kent A; Abu-Isa Eyad; Lawrence Theodore S; Knol James; Zalupski Mark; Ben-Josef Edgar
External-beam radiotherapy for localized extrahepatic cholangiocarcinoma.
International journal of radiation oncology, biology, physics 2006;66(3):772-9.
2006: Ten Haken Randall K; Lawrence Theodore S
The clinical application of intensity-modulated radiation therapy.
Seminars in radiation oncology 2006;16(4):224-31.
2006: Cao Yue; Nagesh Vijaya; Hamstra Daniel; Tsien Christina I; Ross Brian D; Chenevert Thomas L; Junck Larry; Lawrence Theodore S
The extent and severity of vascular leakage as evidence of tumor aggressiveness in high-grade gliomas.
Cancer research 2006;66(17):8912-7.
2006: Morgan Meredith A; Parsels Leslie A; Parsels Joshua D; Lawrence Theodore S; Maybaum Jonathan
The relationship of premature mitosis to cytotoxicity in response to checkpoint abrogation and antimetabolite treatment.
Cell cycle (Georgetown, Tex.) 2006;5(17):1983-8.
2006: Cao Yue; Alspaugh Jonathan; Shen Zhou; Balter James M; Lawrence Theodore S; Ten Haken Randall K
A practical approach for quantitative estimates of voxel-by-voxel liver perfusion using DCE imaging and a compartmental model.
Medical physics 2006;33(8):3057-62.
2006: Ray Michael E; Lawrence Theodore S
Radiation therapy for aggressive fibromatosis (desmoid tumor).
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(22):3714-5; author reply 3715.
2006: Kong Feng-Ming; Hayman James A; Griffith Kent A; Kalemkerian Gregory P; Arenberg Douglas; Lyons Susan; Turrisi Andrew; Lichter Allen; Fraass Benedick; Eisbruch Avraham; Lawrence Theodore S; Ten Haken Randall K
Final toxicity results of a radiation-dose escalation study in patients with non-small-cell lung cancer (NSCLC): predictors for radiation pneumonitis and fibrosis.
International journal of radiation oncology, biology, physics 2006;65(4):1075-86.
2006: Lin Alexander; Lawrence Theodore S
An anaphylactoid reaction from amifostine.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2006;79(3):352.
2006: Spalding Aaron C; Lawrence Theodore S
New and emerging radiosensitizers and radioprotectors.
Cancer investigation 2006;24(4):444-56.
2006: Huang Xiao W; Yang Jiong; Dragovic Aleksandar F; Zhang Hong; Lawrence Theodore S; Zhang Ming
Antisense oligonucleotide inhibition of tumor necrosis factor receptor 1 protects the liver from radiation-induced apoptosis.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(9):2849-55.
2006: Cao Yue; Tsien Christina I; Nagesh Vijaya; Junck Larry; Ten Haken Randall; Ross Brian D; Chenevert Thomas L; Lawrence Theodore S
Survival prediction in high-grade gliomas by MRI perfusion before and during early stage of RT [corrected]
International journal of radiation oncology, biology, physics 2006;64(3):876-85.
2006: Lawrence Theodore S
The role of radiation in liver cancer.
Clinical advances in hematology & oncology : H&O 2006;4(2):113-5.
2006: Chun Patrick Y; Feng Felix Y; Scheurer Ashley M; Davis Mary A; Lawrence Theodore S; Nyati Mukesh K
Synergistic effects of gemcitabine and gefitinib in the treatment of head and neck carcinoma.
Cancer research 2006;66(2):981-8.
2005: Nyati Mukesh K; Lawrence Theodore S
Hitting the target: measuring EGFR response to tyrosine kinase inhibitors.
Cancer biology & therapy 2005;4(12):1387-8.
2005: Ben-Josef Edgar; Normolle Daniel; Ensminger William D; Walker Suzette; Tatro Daniel; Ten Haken Randall K; Knol James; Dawson Laura A; Pan Charlie; Lawrence Theodore S
Phase II trial of high-dose conformal radiation therapy with concurrent hepatic artery floxuridine for unresectable intrahepatic malignancies.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(34):8739-47.
2005: Schneider Bryan J; Ben-Josef Edgar; McGinn Cornelius J; Chang Alfred E; Colletti Lisa M; Normolle Daniel P; Hejna Gwen F; Lawrence Theodore S; Zalupski Mark M
Capecitabine and radiation therapy preceded and followed by combination chemotherapy in advanced pancreatic cancer.
International journal of radiation oncology, biology, physics 2005;63(5):1325-30.
2005: Hamstra Daniel A; Chenevert Thomas L; Moffat Bradford A; Johnson Timothy D; Meyer Charles R; Mukherji Suresh K; Quint Douglas J; Gebarski Stephen S; Fan Xiaoying; Tsien Christina I; Lawrence Theodore S; Junck Larry; Rehemtulla Alnawaz; Ross Brian D
Evaluation of the functional diffusion map as an early biomarker of time-to-progression and overall survival in high-grade glioma.
Proceedings of the National Academy of Sciences of the United States of America 2005;102(46):16759-64.
2005: Ben-Josef Edgar; Lawrence Theodore S
Radiotherapy for unresectable hepatic malignancies.
Seminars in radiation oncology 2005;15(4):273-8.
2005: Morgan Meredith A; Parsels Leslie A; Parsels Joshua D; Mesiwala Alefiyah K; Maybaum Jonathan; Lawrence Theodore S
Role of checkpoint kinase 1 in preventing premature mitosis in response to gemcitabine.
Cancer research 2005;65(15):6835-42.
2005: Huang Canhui; Liu Xiang Y; Rehemtulla Alnawaz; Lawrence Theodore S
Identification of peptides that bind to irradiated pancreatic tumor cells.
International journal of radiation oncology, biology, physics 2005;62(5):1497-503.
2005: Qian Jun; Yang Jiong; Dragovic Aleksandar F; Abu-Isa Eyad; Lawrence Theodore S; Zhang Ming
Ionizing radiation-induced adenovirus infection is mediated by Dynamin 2.
Cancer research 2005;65(13):5493-7.
2005: Dawson Laura A; Biersack Matthew; Lockwood Gina; Eisbruch Avraham; Lawrence Theodore S; Ten Haken Randall K
Use of principal component analysis to evaluate the partial organ tolerance of normal tissues to radiation.
International journal of radiation oncology, biology, physics 2005;62(3):829-37.
2005: Cao Yue; Tsien Christina I; Shen Zhou; Tatro Daniel S; Ten Haken Randall; Kessler Marc L; Chenevert Thomas L; Lawrence Theodore S
Use of magnetic resonance imaging to assess blood-brain/blood-glioma barrier opening during conformal radiotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(18):4127-36.
2005: Thomas Emma; Chapet Olivier; Kessler Marc L; Lawrence Theodore S; Ten Haken Randall K
Benefit of using biologic parameters (EUD and NTCP) in IMRT optimization for treatment of intrahepatic tumors.
International journal of radiation oncology, biology, physics 2005;62(2):571-8.
2005: Chen Jun; Lu Zheng; Lawrence Theodore S; Smith David E
Determination of WR-1065 in human blood by high-performance liquid chromatography following fluorescent derivatization by a maleimide reagent ThioGlo3.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2005;819(1):161-7.
2005: Kong Feng-Ming; Ten Haken Randall; Eisbruch Avraham; Lawrence Theodore S
Non-small cell lung cancer therapy-related pulmonary toxicity: an update on radiation pneumonitis and fibrosis.
Seminars in oncology 2005;32(2 Suppl 3):S42-54.
2005: Li Jun; Tan Mingjia; Li Ling; Pamarthy Deepika; Lawrence Theodore S; Sun Yi
SAK, a new polo-like kinase, is transcriptionally repressed by p53 and induces apoptosis upon RNAi silencing.
Neoplasia (New York, N.Y.) 2005;7(4):312-23.
2005: Moffat Bradford A; Chenevert Thomas L; Lawrence Theodore S; Meyer Charles R; Johnson Timothy D; Dong Qian; Tsien Christina; Mukherji Suresh; Quint Douglas J; Gebarski Stephen S; Robertson Patricia L; Junck Larry R; Rehemtulla Alnawaz; Ross Brian D
Functional diffusion map: a noninvasive MRI biomarker for early stratification of clinical brain tumor response.
Proceedings of the National Academy of Sciences of the United States of America 2005;102(15):5524-9.
2005: Huang Xiao W; Tang Zhao Y; Lawrence Theodore S; Zhang Ming
5-fluorouracil and hydroxyurea enhance adenovirus-mediated transgene expression in colon and hepatocellular carcinoma cells.
Journal of cancer research and clinical oncology 2005;131(3):184-90.
2005: Moran Jean M; Elshaikh Mohamed A; Lawrence Theodore S
Radiotherapy: what can be achieved by technical improvements in dose delivery?
The lancet oncology 2005;6(1):51-8.
2004: Hamstra Daniel A; Lee Kuei C; Tychewicz Joseph M; Schepkin Victor D; Moffat Bradford A; Chen Mark; Dornfeld Kenneth J; Lawrence Theodore S; Chenevert Thomas L; Ross Brian D; Gelovani Juri T; Rehemtulla Alnawaz
The use of 19F spectroscopy and diffusion-weighted MRI to evaluate differences in gene-dependent enzyme prodrug therapies.
Molecular therapy : the journal of the American Society of Gene Therapy 2004;10(5):916-28.
2004: Lawrence Theodore S
Advances in radiosensitization.
Clinical advances in hematology & oncology : H&O 2004;2(9):575-7.
2004: Allen Aaron M; Zalupski Mark M; Robertson John M; Eckhauser Frederic E; Simone Diane; Brown Diane; Hejna Gwen; Normolle Daniel; Lawrence Theodore S; McGinn Cornelius J
Adjuvant therapy in pancreatic cancer: Phase I trial of radiation dose escalation with concurrent full-dose gemcitabine.
International journal of radiation oncology, biology, physics 2004;59(5):1461-7.
2004: Huang Xiao W; Lieber Andre; Tang Zhao Y; Lawrence Theodore S; Moyer Mary P; Zhang Ming
Gene expression in intrahepatic tumors through DNA recombination by a replication-activated adenovirus vector.
Cancer gene therapy 2004;11(6):450-6.
2004: Rehemtulla Alnawaz; Hamstra Daniel A; Kievit Els; Davis Mary A; Ng Emily Y; Dornfeld Kenneth; Lawrence Theodore S
Extracellular expression of cytosine deaminase results in increased 5-FU production for enhanced enzyme/prodrug therapy.
Anticancer research 2004;24(3a):1393-9.
2004: Morgan M A; Poynter J N; Maybaum J; Lawrence T S
The role of Bcl-X(S) in radiation sensitivity.
Radiation research 2004;161(5):535-9.
2004: Dawson Laura A; Lawrence Theodore S
The role of radiotherapy in the treatment of liver metastases.
Cancer journal (Sudbury, Mass.) 2004;10(2):139-44.
2004: Nigavekar Shraddha S; Sung Lok Yun; Llanes Mikel; El-Jawahri Areej; Lawrence Theodore S; Becker Christopher W; Balogh Lajos; Khan Mohamed K
3H dendrimer nanoparticle organ/tumor distribution.
Pharmaceutical research 2004;21(3):476-83.
2004: Nyati Mukesh K; Maheshwari Divya; Hanasoge Sheela; Sreekumar Arun; Rynkiewicz Susan D; Chinnaiyan Arul M; Leopold Wilbur R; Ethier Stephen P; Lawrence Theodore S
Radiosensitization by pan ErbB inhibitor CI-1033 in vitro and in vivo.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(2):691-700.
2003: Lawrence Theodore S
Radiation sensitizers and targeted therapies.
Oncology (Williston Park, N.Y.) 2003;17(12 Suppl 13):23-8.
2003: Rosu Mihaela; Dawson Laura A; Balter James M; McShan Daniel L; Lawrence Theodore S; Ten Haken Randall K
Alterations in normal liver doses due to organ motion.
International journal of radiation oncology, biology, physics 2003;57(5):1472-9.
2003: Ammori John B; Colletti Lisa M; Zalupski Mark M; Eckhauser Frederic E; Greenson Joel K; Dimick Justin; Lawrence Theodore S; McGinn Cornelius J
Surgical resection following radiation therapy with concurrent gemcitabine in patients with previously unresectable adenocarcinoma of the pancreas.
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 2003;7(6):766-72.
2003: Shewach Donna S; Lawrence Theodore S
It's what's inside that counts.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(18):3383-4.
2003: Robinson Megan; Jiang Ping; Cui Jenny; Li Jun; Wang Yuli; Swaroop Manju; Madore Steve; Lawrence Theodore S; Sun Yi
Global genechip profiling to identify genes responsive to p53-induced growth arrest and apoptosis in human lung carcinoma cells.
Cancer biology & therapy 2003;2(4):406-15.
2003: Zhang Ming; Li Shengping; Li Jun; Ensminger William D; Lawrence Theodore S
Ionizing radiation increases adenovirus uptake and improves transgene expression in intrahepatic colon cancer xenografts.
Molecular therapy : the journal of the American Society of Gene Therapy 2003;8(1):21-8.
2003: Ross Brian D; Moffat Bradford A; Lawrence Theodore S; Mukherji Suresh K; Gebarski Stephen S; Quint Douglas J; Johnson Timothy D; Junck Larry; Robertson Patricia L; Muraszko Karin M; Dong Qian; Meyer Charles R; Bland Peyton H; McConville Patrick; Geng Hairong; Rehemtulla Alnawaz; Chenevert Thomas L
Evaluation of cancer therapy using diffusion magnetic resonance imaging.
Molecular cancer therapeutics 2003;2(6):581-7.
2003: Li Jun; Jiang Ping; Robinson Megan; Lawrence Theodore S; Sun Yi
AMPK-beta1 subunit is a p53-independent stress responsive protein that inhibits tumor cell growth upon forced expression.
Carcinogenesis 2003;24(5):827-34.
2003: Zhang Ming; Li Shengping; Nyati Mukesh K; DeRemer Susan; Parsels Joshua; Rehemtulla Alnawaz; Ensminger William D; Lawrence Theodore S
Regional delivery and selective expression of a high-activity yeast cytosine deaminase in an intrahepatic colon cancer model.
Cancer research 2003;63(3):658-63.
2003: Lawrence Theodore S; Blackstock A William; McGinn Cornelius
The mechanism of action of radiosensitization of conventional chemotherapeutic agents.
Seminars in radiation oncology 2003;13(1):13-21.
2003: Dawson Laura A; McGinn Cornelius J; Lawrence Theodore S
Conformal chemoradiation for primary and metastatic liver malignancies.
Seminars in surgical oncology 2003;21(4):249-55.
2002: Chenevert Thomas L; Meyer Charles R; Moffat Bradford A; Rehemtulla Alnawaz; Mukherji Suresh K; Gebarski Stephen S; Quint Douglas J; Robertson Patricia L; Lawrence Theodore S; Junck Larry; Taylor Jeremy M; Johnson Timothy D; Dong Qian; Muraszko Karin M; Brunberg James A; Ross Brian D
Diffusion MRI: a new strategy for assessment of cancer therapeutic efficacy.
Molecular imaging : official journal of the Society for Molecular Imaging 2002;1(4):336-43.
2002: McGinn Cornelius J; Lawrence Theodore S; Zalupski Mark M
On the development of gemcitabine-based chemoradiotherapy regimens in pancreatic cancer.
Cancer 2002;95(4 Suppl):933-40.
2002: Lawrence Theodore S; Nyati Mukesh K
Small-molecule tyrosine kinase inhibitors as radiosensitizers.
Seminars in radiation oncology 2002;12(3 Suppl 2):33-6.
2002: Dawson Laura A; Normolle Daniel; Balter James M; McGinn Cornelius J; Lawrence Theodore S; Ten Haken Randall K
Analysis of radiation-induced liver disease using the Lyman NTCP model.
International journal of radiation oncology, biology, physics 2002;53(4):810-21.
2002: Nyati M K; Symon Z; Kievit E; Dornfeld K J; Rynkiewicz S D; Ross B D; Rehemtulla A; Lawrence T S
The potential of 5-fluorocytosine/cytosine deaminase enzyme prodrug gene therapy in an intrahepatic colon cancer model.
Gene therapy 2002;9(13):844-9.
2002: Symon Zvi; Davis Mary; McGinn Cornelius J; Zalupski Mark M; Lawrence Theodore S
Concurrent chemoradiotherapy with gemcitabine and cisplatin for pancreatic cancer: from the laboratory to the clinic.
International journal of radiation oncology, biology, physics 2002;53(1):140-5.
2002: Nyati Mukesh K; Sreekumar Arun; Li Shengping; Zhang Ming; Rynkiewicz Susan D; Chinnaiyan Arul M; Rehemtulla Alnawaz; Lawrence Theodore S
High and selective expression of yeast cytosine deaminase under a carcinoembryonic antigen promoter-enhancer.
Cancer research 2002;62(8):2337-42.
2002: Li Jun; Wang Yuli; Sun Yi; Lawrence Theodore S
Wild-type TP53 inhibits G(2)-phase checkpoint abrogation and radiosensitization induced by PD0166285, a WEE1 kinase inhibitor.
Radiation research 2002;157(3):322-30.
2002: Balter James M; Brock Kristy K; Litzenberg Dale W; McShan Daniel L; Lawrence Theodore S; Ten Haken Randall; McGinn Cornelius J; Lam Kwok L; Dawson Laura A
Daily targeting of intrahepatic tumors for radiotherapy.
International journal of radiation oncology, biology, physics 2002;52(1):266-71.
2001: Dawson L A; Brock K K; Kazanjian S; Fitch D; McGinn C J; Lawrence T S; Ten Haken R K; Balter J
The reproducibility of organ position using active breathing control (ABC) during liver radiotherapy.
International journal of radiation oncology, biology, physics 2001;51(5):1410-21.
2001: Wang Y; Li J; Booher R N; Kraker A; Lawrence T; Leopold W R; Sun Y
Radiosensitization of p53 mutant cells by PD0166285, a novel G(2) checkpoint abrogator.
Cancer research 2001;61(22):8211-7.
2001: McGinn C J; Zalupski M M; Shureiqi I; Robertson J M; Eckhauser F E; Smith D C; Brown D; Hejna G; Strawderman M; Normolle D; Lawrence T S
Phase I trial of radiation dose escalation with concurrent weekly full-dose gemcitabine in patients with advanced pancreatic cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(22):4202-8.
2001: Ding Z; Parchment R E; LoRusso P M; Zhou J Y; Li J; Lawrence T S; Sun Y; Wu G S
The investigational new drug XK469 induces G(2)-M cell cycle arrest by p53-dependent and -independent pathways.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(11):3336-42.
2001: McGinn C J; Lawrence T S
Recent advances in the use of radiosensitizing nucleosides.
Seminars in radiation oncology 2001;11(4):270-80.
2001: Sreekumar A; Nyati M K; Varambally S; Barrette T R; Ghosh D; Lawrence T S; Chinnaiyan A M
Profiling of cancer cells using protein microarrays: discovery of novel radiation-regulated proteins.
Cancer research 2001;61(20):7585-93.
2001: Dawson L A; Ten Haken R K; Lawrence T S
Partial irradiation of the liver.
Seminars in radiation oncology 2001;11(3):240-6.
2001: Symon Z; Levi M; Ensminger W D; Smith D E; Lawrence T S
Selective radioprotection of hepatocytes by systemic and portal vein infusions of amifostine in a rat liver tumor model.
International journal of radiation oncology, biology, physics 2001;50(2):473-8.
2001: Lawrence T S; Davis M A; Hough A; Rehemtulla A
The role of apoptosis in 2',2'-difluoro-2'-deoxycytidine (gemcitabine)-mediated radiosensitization.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(2):314-9.
2001: Eisbruch A; Shewach D S; Bradford C R; Littles J F; Teknos T N; Chepeha D B; Marentette L J; Terrell J E; Hogikyan N D; Dawson L A; Urba S; Wolf G T; Lawrence T S
Radiation concurrent with gemcitabine for locally advanced head and neck cancer: a phase I trial and intracellular drug incorporation study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(3):792-9.
2000: Kievit E; Nyati M K; Ng E; Stegman L D; Parsels J; Ross B D; Rehemtulla A; Lawrence T S
Yeast cytosine deaminase improves radiosensitization and bystander effect by 5-fluorocytosine of human colorectal cancer xenografts.
Cancer research 2000;60(23):6649-55.
2000: Lawrence T S; Burke R; Davis M A
Lack of effect of TP53 status on fluorodeoxyuridine-mediated radiosensitization.
Radiation research 2000;154(2):140-4.
2000: Fields M T; Eisbruch A; Normolle D; Orfali A; Davis M A; Pu A T; Lawrence T S
Radiosensitization produced in vivo by once- vs. twice-weekly 2'2'-difluoro-2'-deoxycytidine (gemcitabine).
International journal of radiation oncology, biology, physics 2000;47(3):785-91.
2000: Dawson L A; McGinn C J; Normolle D; Ten Haken R K; Walker S; Ensminger W; Lawrence T S
Escalated focal liver radiation and concurrent hepatic artery fluorodeoxyuridine for unresectable intrahepatic malignancies.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(11):2210-8.
2000: Chen M; Hough A M; Lawrence T S
The role of p53 in gemcitabine-mediated cytotoxicity and radiosensitization.
Cancer chemotherapy and pharmacology 2000;45(5):369-74.
2000: Aung T T; Davis M A; Ensminger W D; Lawrence T S
Interaction between gemcitabine and mitomycin-C in vitro.
Cancer chemotherapy and pharmacology 2000;45(1):38-42.
1999: Lawrence T S; Eisbruch A; McGinn C J; Fields M T; Shewach D S
Radiosensitization by gemcitabine.
Oncology (Williston Park, N.Y.) 1999;13(10 Suppl 5):55-60.
1999: Shureiqi I; Wojno K J; Poore J A; Reddy R G; Moussalli M J; Spindler S A; Greenson J K; Normolle D; Hasan A A; Lawrence T S; Brenner D E
Decreased 13-S-hydroxyoctadecadienoic acid levels and 15-lipoxygenase-1 expression in human colon cancers.
Carcinogenesis 1999;20(10):1985-95.
1999: Stegman L D; Rehemtulla A; Beattie B; Kievit E; Lawrence T S; Blasberg R G; Tjuvajev J G; Ross B D
Noninvasive quantitation of cytosine deaminase transgene expression in human tumor xenografts with in vivo magnetic resonance spectroscopy.
Proceedings of the National Academy of Sciences of the United States of America 1999;96(17):9821-6.
1999: Axelson M D; Davis M A; Ethier S P; Lawrence T S
HPV16-E7 expression causes fluorodeoxyuridine-mediated radiosensitization in SW620 human colon cancer cells.
Neoplasia (New York, N.Y.) 1999;1(2):177-82.
1999: Martel M K; Ten Haken R K; Hazuka M B; Kessler M L; Strawderman M; Turrisi A T; Lawrence T S; Fraass B A; Lichter A S
Estimation of tumor control probability model parameters from 3-D dose distributions of non-small cell lung cancer patients.
Lung cancer (Amsterdam, Netherlands) 1999;24(1):31-7.
1999: Kievit E; Bershad E; Ng E; Sethna P; Dev I; Lawrence T S; Rehemtulla A
Superiority of yeast over bacterial cytosine deaminase for enzyme/prodrug gene therapy in colon cancer xenografts.
Cancer research 1999;59(7):1417-21.
1999: Eisbruch A; Robertson J M; Johnston C M; Tworek J; Reynolds K R; Roberts J A; Lawrence T S
Bromodeoxyuridine alternating with radiation for advanced uterine cervix cancer: a phase I and drug incorporation study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(1):31-40.
1998: Balter J M; Lam K L; McGinn C J; Lawrence T S; Ten Haken R K
Improvement of CT-based treatment-planning models of abdominal targets using static exhale imaging.
International journal of radiation oncology, biology, physics 1998;41(4):939-43.
1998: Naida J D; Davis M A; Lawrence T S
The effect of activation of wild-type p53 function on fluoropyrimidine-mediated radiosensitization.
International journal of radiation oncology, biology, physics 1998;41(3):675-80.
1998: Lawrence T S; Rehemtulla A; Ng E Y; Wilson M; Trosko J E; Stetson P L
Preferential cytotoxicity of cells transduced with cytosine deaminase compared to bystander cells after treatment with 5-flucytosine.
Cancer research 1998;58(12):2588-93.
1998: McGinn C J; Ten Haken R K; Ensminger W D; Walker S; Wang S; Lawrence T S
Treatment of intrahepatic cancers with radiation doses based on a normal tissue complication probability model.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(6):2246-52.
1998: Martel M K; Eisbruch A; Lawrence T S; Fraass B A; Ten Haken R K; Lichter A S
Spinal cord dose from standard head and neck irradiation: implications for three-dimensional treatment planning.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1998;47(2):185-9.
1998: Sondak V K; Robertson J M; Sussman J J; Saran P A; Chang A E; Lawrence T S
Preoperative idoxuridine and radiation for large soft tissue sarcomas: clinical results with five-year follow-up.
Annals of surgical oncology 1998;5(2):106-12.
1997: Robertson J M; McGinn C J; Walker S; Marx M V; Kessler M L; Ensminger W D; Lawrence T S
A phase I trial of hepatic arterial bromodeoxyuridine and conformal radiation therapy for patients with primary hepatobiliary cancers or colorectal liver metastases.
International journal of radiation oncology, biology, physics 1997;39(5):1087-92.
1997: Parsels L A; Zellars R C; Loney T L; Parsels J D; Clarke M F; Merchant A K; Lawrence T S; Maybaum J
Prevention of fluorodeoxyuridine-induced cytotoxicity and DNA damage in HT29 colon carcinoma cells by conditional expression of wild-type p53 phenotype.
Molecular pharmacology 1997;52(4):600-5.
1997: Ten Haken R K; Balter J M; Marsh L H; Robertson J M; Lawrence T S
Potential benefits of eliminating planning target volume expansions for patient breathing in the treatment of liver tumors.
International journal of radiation oncology, biology, physics 1997;38(3):613-7.
1997: Lawrence T S; Chang E Y; Hahn T M; Shewach D S
Delayed radiosensitization of human colon carcinoma cells after a brief exposure to 2',2'-difluoro-2'-deoxycytidine (Gemcitabine).
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(5):777-82.
1997: Wygoda M R; Wilson M R; Davis M A; Trosko J E; Rehemtulla A; Lawrence T S
Protection of herpes simplex virus thymidine kinase-transduced cells from ganciclovir-mediated cytotoxicity by bystander cells: the Good Samaritan effect.
Cancer research 1997;57(9):1699-703.
1997: Lawrence T S; Eisbruch A; Shewach D S
Gemcitabine-mediated radiosensitization.
Seminars in oncology 1997;24(2 Suppl 7):S7-24-S7-28.
1997: Robertson J M; Ensminger W D; Walker S; Lawrence T S
A phase I trial of intravenous bromodeoxyuridine and radiation therapy for pancreatic cancer.
International journal of radiation oncology, biology, physics 1997;37(2):331-5.
1997: Robertson J M; Lawrence T S; Andrews J C; Walker S; Kessler M L; Ensminger W D
Long-term results of hepatic artery fluorodeoxyuridine and conformal radiation therapy for primary hepatobiliary cancers.
International journal of radiation oncology, biology, physics 1997;37(2):325-30.
1997: Zellars R C; Naida J D; Davis M A; Lawrence T S
Effect of p53 overexpression on radiation sensitivity of human colon cancer cells.
Radiation oncology investigations 1997;5(2):43-9.
1996: Shewach D S; Lawrence T S
Radiosensitization of human solid tumor cell lines with gemcitabine.
Seminars in oncology 1996;23(5 Suppl 10):65-71.
1996: Lawrence T S; Davis M A; Tang H Y; Maybaum J
Fluorodeoxyuridine-mediated cytotoxicity and radiosensitization require S phase progression.
International journal of radiation biology 1996;70(3):273-80.
1996: McGinn C J; Shewach D S; Lawrence T S
Radiosensitizing nucleosides.
Journal of the National Cancer Institute 1996;88(17):1193-203.
1996: Balter J M; Ten Haken R K; Lawrence T S; Lam K L; Robertson J M
Uncertainties in CT-based radiation therapy treatment planning associated with patient breathing.
International journal of radiation oncology, biology, physics 1996;36(1):167-74.
1996: Robertson J M; Shewach D S; Lawrence T S
Preclinical studies of chemotherapy and radiation therapy for pancreatic carcinoma.
Cancer 1996;78(3 Suppl):674-9.
1996: Lawrence T S; Davis M A; Loney T L
Fluoropyrimidine-mediated radiosensitization depends on cyclin E-dependent kinase activation.
Cancer research 1996;56(14):3203-6.
1996: Lawrence T S; Chang E Y; Hahn T M; Hertel L W; Shewach D S
Radiosensitization of pancreatic cancer cells by 2',2'-difluoro-2'-deoxycytidine.
International journal of radiation oncology, biology, physics 1996;34(4):867-72.
1996: Lawrence T S; Chang E Y; Davis M A; Stetson P L; Ensminger W D
Effect of irradiation on bromodeoxyuridine incorporation in human colon cancer xenografts.
International journal of radiation oncology, biology, physics 1996;34(3):617-21.
1996: Robertson J M; Cha C; Andrews J C; Ensminger W D; Lawrence T S
Pelvic radiation therapy combined with hepatic artery chemotherapy for resected rectal carcinoma with liver metastases.
International journal of radiation oncology, biology, physics 1996;34(1):155-9.
1996: Shewach D S; Lawrence T S
Gemcitabine and radiosensitization in human tumor cells.
Investigational new drugs 1996;14(3):257-63.
1996: Lawrence T S; Kessler M L; Robertson J M
3-D conformal radiation therapy in upper gastrointestinal cancer. The University of Michigan experience.
Frontiers of radiation therapy and oncology 1996;29():221-8.
1996: Lawrence T S; Kessler M L; Ten Haken R K
Clinical interpretation of dose-volume histograms: the basis for normal tissue preservation and tumor dose escalation.
Frontiers of radiation therapy and oncology 1996;29():57-66.
1996: Tang H Y; Weber K L; Lawrence T S; Merchant A K; Maybaum J
Dependence of fluorodeoxyuridine-induced cytotoxicity and megabase DNA fragment formation on S phase progression in HT29 cells.
Cancer chemotherapy and pharmacology 1996;37(5):486-90.
1995: Lawrence T S; Davis M A; Normolle D P
Effect of bromodeoxyuridine on radiation-induced DNA damage and repair based on DNA fragment size using pulsed-field gel electrophoresis.
Radiation research 1995;144(3):282-7.
1995: Lawrence T S; Davis M A; Chang E Y; Canman C E; Maybaum J; Radany E H
Lack of dependence of 5-fluorodeoxyuridine-mediated radiosensitization on cytotoxicity.
Radiation research 1995;143(3):281-5.
1995: Knol J A; Walker S C; Robertson J M; Yang Z; DeRemer S; Stetson P L; Ensminger W D; Lawrence T S
Incorporation of 5-bromo-2'-deoxyuridine into colorectal liver metastases and liver in patients receiving a 7-day hepatic arterial infusion.
Cancer research 1995;55(17):3687-91.
1995: Pu A T; Robertson J M; Lawrence T S
Current status of radiation sensitization by fluoropyrimidines.
Oncology (Williston Park, N.Y.) 1995;9(8):707-14; discussion 714, 717-8, 721.
1995: Shewach D S; Lawrence T S
Radiosensitization of human tumor cells by gemcitabine in vitro.
Seminars in oncology 1995;22(4 Suppl 11):68-71.
1995: Yamasaki S A; Marn C S; Francis I R; Robertson J M; Lawrence T S
High-dose localized radiation therapy for treatment of hepatic malignant tumors: CT findings and their relation to radiation hepatitis.
AJR. American journal of roentgenology 1995;165(1):79-84.
1995: Davis M A; Tang H Y; Maybaum J; Lawrence T S
Dependence of fluorodeoxyuridine-mediated radiosensitization on S phase progression.
International journal of radiation biology 1995;67(5):509-17.
1995: Robertson J M; Lawrence T S; Walker S; Kessler M L; Andrews J C; Ensminger W D
The treatment of colorectal liver metastases with conformal radiation therapy and regional chemotherapy.
International journal of radiation oncology, biology, physics 1995;32(2):445-50.
1995: Lawrence T S; Robertson J M; Anscher M S; Jirtle R L; Ensminger W D; Fajardo L F
Hepatic toxicity resulting from cancer treatment.
International journal of radiation oncology, biology, physics 1995;31(5):1237-48.
1995: Jackson A; Ten Haken R K; Robertson J M; Kessler M L; Kutcher G J; Lawrence T S
Analysis of clinical complication data for radiation hepatitis using a parallel architecture model.
International journal of radiation oncology, biology, physics 1995;31(4):883-91.
1995: Lichter A S; Lawrence T S
Recent advances in radiation oncology.
The New England journal of medicine 1995;332(6):371-9.
1995: Robertson J M; Sondak V K; Weiss S A; Sussman J J; Chang A E; Lawrence T S
Preoperative radiation therapy and iododeoxyuridine for large retroperitoneal sarcomas.
International journal of radiation oncology, biology, physics 1995;31(1):87-92.
1994: Wilt S R; Burgess A C; Normolle D P; Trent J M; Lawrence T S
Use of fluorescence in situ hybridization (FISH) to study chromosomal damage induced by radiation and bromodeoxyuridine in human colon cancer cells.
International journal of radiation oncology, biology, physics 1994;30(4):861-6.
1994: McLaughlin P W; Lawrence T S; Seabury H; Nguyen N; Stetson P L; Greenberg H S; Mancini W R
Bromodeoxyuridine-mediated radiosensitization in human glioma: the effect of concentration, duration, and fluoropyrimidine modulation.
International journal of radiation oncology, biology, physics 1994;30(3):601-7.
1994: Robertson J M; Kessler M L; Lawrence T S
Clinical results of three-dimensional conformal irradiation.
Journal of the National Cancer Institute 1994;86(13):968-74.
1994: Shewach D S; Hahn T M; Chang E; Hertel L W; Lawrence T S
Metabolism of 2',2'-difluoro-2'-deoxycytidine and radiation sensitization of human colon carcinoma cells.
Cancer research 1994;54(12):3218-23.
1994: Lawrence T S; Davis M A; Stetson P L; Maybaum J; Ensminger W D
Kinetics of bromodeoxyuridine elimination from human colon cancer cells in vitro and in vivo.
Cancer research 1994;54(11):2964-8.
1994: Lawrence T S; Davis M A; Maybaum J
Dependence of 5-fluorouracil-mediated radiosensitization on DNA-directed effects.
International journal of radiation oncology, biology, physics 1994;29(3):519-23.
1994: Canman C E; Radany E H; Parsels L A; Davis M A; Lawrence T S; Maybaum J
Induction of resistance to fluorodeoxyuridine cytotoxicity and DNA damage in human tumor cells by expression of Escherichia coli deoxyuridinetriphosphatase.
Cancer research 1994;54(9):2296-8.
1994: Ensminger W D; Walker S C; Stetson P L; Wagner J G; Knol J A; Lawrence T S; Andrews J C
Clinical pharmacology of hepatic arterial infusions of 5-bromo-2'-deoxyuridine.
Cancer research 1994;54(8):2121-4.
1994: Tang H; Davis M A; Strickfaden S M; Maybaum J; Lawrence T S
Influence of cell cycle phase on radiation-induced cytotoxicity and DNA damage in human colon cancer (HT29) and Chinese hamster ovary cells.
Radiation research 1994;138(1 Suppl):S109-12.
1994: Buchsbaum D J; Khazaeli M B; Davis M A; Lawrence T S
Sensitization of radiolabeled monoclonal antibody therapy using bromodeoxyuridine.
Cancer 1994;73(3 Suppl):999-1005.
1993: Canman C E; Lawrence T S; Shewach D S; Tang H Y; Maybaum J
Resistance to fluorodeoxyuridine-induced DNA damage and cytotoxicity correlates with an elevation of deoxyuridine triphosphatase activity and failure to accumulate deoxyuridine triphosphate.
Cancer research 1993;53(21):5219-24.
1993: Ten Haken R K; Martel M K; Kessler M L; Hazuka M B; Lawrence T S; Robertson J M; Turrisi A T; Lichter A S
Use of Veff and iso-NTCP in the implementation of dose escalation protocols.
International journal of radiation oncology, biology, physics 1993;27(3):689-95.
1993: Lawrence T S; Normolle D P; Davis M A; Maybaum J
The use of biphasic linear ramped pulsed field gel electrophoresis to quantify DNA damage based on fragment size distribution.
International journal of radiation oncology, biology, physics 1993;27(3):659-63.
1993: Robertson J M; Lawrence T S; Dworzanin L M; Andrews J C; Walker S; Kessler M L; DuRoss D J; Ensminger W D
Treatment of primary hepatobiliary cancers with conformal radiation therapy and regional chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(7):1286-93.
1993: McLaughlin P W; Mancini W R; Stetson P L; Greenberg H S; Nguyen N; Seabury H; Heidorn D B; Lawrence T S
Halogenated pyrimidine sensitization of low dose rate irradiation in human malignant glioma.
International journal of radiation oncology, biology, physics 1993;26(4):637-42.
1993: Buchsbaum D J; Lawrence T S; Roberson P L; Heidorn D B; Ten Haken R K; Steplewski Z
Comparison of 131I- and 90Y-labeled monoclonal antibody 17-1A for treatment of human colon cancer xenografts.
International journal of radiation oncology, biology, physics 1993;25(4):629-38.
1992: Canman C E; Tang H Y; Normolle D P; Lawrence T S; Maybaum J
Variations in patterns of DNA damage induced in human colorectal tumor cells by 5-fluorodeoxyuridine: implications for mechanisms of resistance and cytotoxicity.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(21):10474-8.
1992: Lawrence T S; Davis M A; Maybaum J; Mukhopadhyay S K; Stetson P L; Normolle D P; McKeever P E; Ensminger W D
The potential superiority of bromodeoxyuridine to iododeoxyuridine as a radiation sensitizer in the treatment of colorectal cancer.
Cancer research 1992;52(13):3698-704.
1992: Robertson J M; Marsh L; Ten Haken R K; Lawrence T S
The clinical application of a non-axial treatment plan for pancreatic and biliary malignancies.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1992;24(3):198-200.
1992: Lawrence T S; Davis M A; Maybaum J; Stetson P L; Ensminger W D
Modulation of iododeoxyuridine-mediated radiosensitization by 5-fluorouracil in human colon cancer cells.
International journal of radiation oncology, biology, physics 1992;22(3):499-503.
1992: Lawrence T S; Ten Haken R K; Kessler M L; Robertson J M; Lyman J T; Lavigne M L; Brown M B; DuRoss D J; Andrews J C; Ensminger W D
The use of 3-D dose volume analysis to predict radiation hepatitis.
International journal of radiation oncology, biology, physics 1992;23(4):781-8.
1992: Bonner J A; Christianson T J; Lawrence T S
Interaction of buthionine sulfoximine and the stabilization of DNA-topoisomerase II complexes by doxorubicin.
International journal of radiation oncology, biology, physics 1992;22(3):519-23.
1991: Ten Haken R K; Lawrence T S; McShan D L; Tesser R J; Fraass B A; Lichter A S
Technical considerations in the use of 3-D beam arrangements in the abdomen.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1991;22(1):19-28.
1991: Heimburger D K; Shewach D S; Lawrence T S
The effect of fluorodeoxyuridine on sublethal damage repair in human colon cancer cells.
International journal of radiation oncology, biology, physics 1991;21(4):983-7.
1991: Lawrence T S; Davis M A; McKeever P E; Maybaum J; Stetson P L; Normolle D P; Ensminger W D
Fluorodeoxyuridine-mediated modulation of iododeoxyuridine incorporation and radiosensitization in human colon cancer cells in vitro and in vivo.
Cancer research 1991;51(15):3900-5.
1991: Lawrence T S; Dworzanin L M; Walker-Andrews S C; Andrews J C; Ten Haken R K; Wollner I S; Lichter A S; Ensminger W D
Treatment of cancers involving the liver and porta hepatis with external beam irradiation and intraarterial hepatic fluorodeoxyuridine.
International journal of radiation oncology, biology, physics 1991;20(3):555-61.
1991: Dusenbury C E; Davis M A; Lawrence T S; Maybaum J
Induction of megabase DNA fragments by 5-fluorodeoxyuridine in human colorectal tumor (HT29) cells.
Molecular pharmacology 1991;39(3):285-9.
1991: Lawrence T S; Heimburger D K; Shewach D S
The effects of leucovorin and dipyridamole on fluoropyrimidine-induced radiosensitization.
International journal of radiation oncology, biology, physics 1991;20(2):377-81.
1991: Mancini W R; Stetson P L; Lawrence T S; Wagner J G; Greenberg H S; Ensminger W D
Variability of 5-bromo-2'-deoxyuridine incorporation into DNA of human glioma cell lines and modulation with fluoropyrimidines.
Cancer research 1991;51(3):870-4.
1990: Bruso C E; Shewach D S; Lawrence T S
Fluorodeoxyuridine-induced radiosensitization and inhibition of DNA double strand break repair in human colon cancer cells.
International journal of radiation oncology, biology, physics 1990;19(6):1411-7.
1990: Lawrence T S; Tesser R J; ten Haken R K
An application of dose volume histograms to the treatment of intrahepatic malignancies with radiation therapy.
International journal of radiation oncology, biology, physics 1990;19(4):1041-7.
1990: Lawrence T S; Davis M A; Maybaum J; Stetson P L; Ensminger W D
The effect of single versus double-strand substitution on halogenated pyrimidine-induced radiosensitization and DNA strand breakage in human tumor cells.
Radiation research 1990;123(2):192-8.
1990: Lawrence T S; Davis M A; Maybaum J; Stetson P L; Ensminger W D
The dependence of halogenated pyrimidine incorporation and radiosensitization on the duration of drug exposure.
International journal of radiation oncology, biology, physics 1990;18(6):1393-8.
1990: Buchsbaum D J; ten Haken R K; Heidorn D B; Lawrence T S; Glatfelter A A; Terry V H; Guilbault D M; Steplewski Z; Lichter A S
A comparison of 131I-labeled monoclonal antibody 17-1A treatment to external beam irradiation on the growth of LS174T human colon carcinoma xenografts.
International journal of radiation oncology, biology, physics 1990;18(5):1033-41.
1990: Bonner J A; Lawrence T S
Doxorubicin decreases the repair of radiation-induced DNA damage.
International journal of radiation biology 1990;57(1):55-64.
1990: Lawrence T S; Davis M A
The influence of Na+,K(+)-pump blockade on doxorubicin-mediated cytotoxicity and DNA strand breakage in human tumor cells.
Cancer chemotherapy and pharmacology 1990;26(3):163-7.
1990: Buchsbaum D J; Lawrence T S
New trends in the use of radioimmunoconjugates for the therapy of cancer.
Targeted diagnosis and therapy 1990;3():215-55.
1989: Lawrence T S; Canman C E; Maybaum J; Davis M A
Dependence of etoposide-induced cytotoxicity and topoisomerase II-mediated DNA strand breakage on the intracellular ionic environment.
Cancer research 1989;49(17):4775-9.
1989: Lawrence T S; Davis M A
Selective radiosensitization and cytotoxicity of human melanoma cells using halogenated deoxycytidines and tetrahydrouridine.
International journal of radiation oncology, biology, physics 1989;16(5):1243-6.
1989: Bonner J A; Lawrence T S
Protection of doxorubicin cytotoxicity by cycloheximide.
International journal of radiation oncology, biology, physics 1989;16(5):1209-12.
1988: Lawrence T S
Ouabain sensitizes tumor cells but not normal cells to radiation.
International journal of radiation oncology, biology, physics 1988;15(4):953-8.
1988: Lawrence T S; Urba W J; Steinberg S M; Sundeen J T; Cossman J; Young R C; Glatstein E
Retrospective analysis of stage I and II indolent lymphomas at the National Cancer Institute.
International journal of radiation oncology, biology, physics 1988;14(3):417-24.
1988: Lawrence T S
Reduction of doxorubicin cytotoxicity by ouabain: correlation with topoisomerase-induced DNA strand breakage in human and hamster cells.
Cancer research 1988;48(3):725-30.
1985: Wilding G; Caruso R; Lawrence T S; Ostchega Y; Ballintine E J; Young R C; Ozols R F
Retinal toxicity after high-dose cisplatin therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1985;3(12):1683-9.
1981: Dekel N; Lawrence T S; Gilula N B; Beers W H
Modulation of cell-to-cell communication in the cumulus-oocyte complex and the regulation of oocyte maturation by LH.
Developmental biology 1981;86(2):356-62.
1981: Hertzberg E L; Lawrence T S; Gilula N B
Gap junctional communication.
Annual review of physiology 1981;43():479-91.
1980: Lawrence T S; Dekel N; Beers W H
Binding of human chorionic gonadotropin by rat cumuli oophori and granulosa cells: a comparative study.
Endocrinology 1980;106(4):1114-8.
1979: Lawrence T S; Ginzberg R D; Gilula N B; Beers W H
Hormonally induced cell shape changes in cultured rat ovarian granulosa cells.
The Journal of cell biology 1979;80(1):21-36.
1978: Lawrence T S; Beers W H; Gilula N B
Transmission of hormonal stimulation by cell-to-cell communication.
Nature 1978;272(5653):501-6.
1974: Lawrence T S; Velleman J D
Correlates of student drug use in a suburban high school.
Psychiatry 1974;37(2):129-36.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Theodore Lawrence

Research Profile (preview)

Chemicals & Drugs

Anatomy

Disorders

Concepts & Ideas

Procedures

Physiology

Living Beings

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Theodore Lawrence (preview)

All Publications